Ackman Has Evidence Of Misleading Allergan Statements, He Just Hasn't Seen It Yet – ValueWalk Premium
Bill Ackman

Ackman Has Evidence Of Misleading Allergan Statements, He Just Hasn't Seen It Yet

Bill Ackman says he has evidence that Allergan, Inc. (NYSE:AGN) officials knowingly delivered false and misleading information to their investors regarding the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) takeover bid. He just hasn't personally seen the evidence yet.

Speaking at a conference in Toronto, Ackman told reporters “We believe they put those statements out [and that] they knew they were false at the time that they made . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0